Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv

Subscribe to access this work and thousands more

Contents

ABSTRACT......................................................................................................................................................4

DECLARATION ..........................................................................................................................................5

APPROVAL .................................................................................................................................................6

DEDICATION..............................................................................................................................................7

ACKNOWLEDGEMENT ............................................................................................................................8

LIST OF ACRONYMS ................................................................................................................................9

CHAPTER 1 ...............................................................................................................................................10

1.0 INTRODUCTION...................................................................................................................................................10

1.1 BACKGROUND INFORMATION.............................................................................................................................10

1.2 PROBLEM STATEMENT........................................................................................................................................11

1.3 JUSTIFICATION OF STUDY...................................................................................................................................12

1.4.0 RESEARCH OBJECTIVES...................................................................................................................................12

1.4.1 Broad Objective .........................................................................................................................................12

1.4.2 Specific Objectives.................................................................................................................................13

1.5 RESEARCH QUESTIONS.......................................................................................................................................13

1.6 SCOPE OF THE STUDY.........................................................................................................................................13

1.6.1 Time Scope.................................................................................................................................................13

1.6.2 Content Scope ............................................................................................................................................14

1.6.3 Geographical Scope...................................................................................................................................14

1.7 CONCEPTUAL FRAMEWORK................................................................................................................................15

CHAPTER 2: LITERATURE REVIEW ....................................................................................................16

CHAPTER 3: METHODOLOGY ..............................................................................................................24

3.1 INTRODUCTIONS.................................................................................................................................................24

3.2 STUDY DESIGN...................................................................................................................................................24

3.3 STUDY POPULATION...........................................................................................................................................24

3.4 STUDY POPULATION...........................................................................................................................................24

3.5 SAMPLING METHODS. .........................................................................................................................................25

3.5.1 Inclusion criteria........................................................................................................................................25

3.5.2 Exclusion Criteria......................................................................................................................................26

3.6: SAMPLE SIZE DETERMINATION. .........................................................................................................................26

3.7. DATA COLLECTION METHODS............................................................................................................................27

3.8. QUALITY CONTROL. ..........................................................................................................................................27

3.9 DATA ANALYSIS AND PRESENTATIONS ...............................................................................................................27

3.10. ETHICAL CONSIDERATION. ..............................................................................................................................27

CHAPTER 4: STUDY RESULTS..............................................................................................................29

4.0 INTRODUCTION...................................................................................................................................................29

4.0.1 DEMOGRAPHIC INFORMATION.........................................................................................................................29

3

Figure 1: Gender................................................................................................................................................29

Figure 2: Age distribution ..................................................................................................................................30

Table 1: Age distribution ....................................................................................................................................30

Figure 3: Tribe....................................................................................................................................................31

Figure 4: Marital status......................................................................................................................................31

Table 2: Marital status........................................................................................................................................31

Figure 5: Level of education...............................................................................................................................32

Figure 6: Knowledge on adherence to MDR-TB treatment................................................................................32

4.0.2 LEVEL OF ADHERENCE ....................................................................................................................................33

Table 3: Days missed taking drugs...................................................................................................................33

Figure 7: Those whose treatments were observed ..............................................................................................33

Figure 8: Person who observed treatment..........................................................................................................33

Figure 9: Those who have ever missed their dose of MDR-TB drugs.................................................................34

Table 4: Those who have experienced side effects from drugs they are currently using and affected adherence

............................................................................................................................................................................35

Table 5: Distance from the health facility affecting adherence to medication ...................................................35

Table 6: Those who have received counselling concerning their treatment .......................................................35

Figure 10: Number of counselling sessions........................................................................................................36

Table 7: Those who have received any form of financial support ......................................................................36

CHAPTER 5: DISCUSSION, CONCLUSION AND RECOMMENDATION .........................................37

5.1: DISCUSSION OF FINDINGS ..................................................................................................................................37

5.2 CONCLUSION......................................................................................................................................................38

5.3 RECOMMENDATION............................................................................................................................................38

REFERENCES ...........................................................................................................................................40

APPENDICES ............................................................................................................................................42

APPENDIX 1: RESEARCH QUESTIONNAIRE SHEET......................................................................................42

APPENDIX 2: MAP OF MUKONO .......................................................................................................................47

APPENDIX 3: MAP OF UGANDA........................................................................................................................48

ABSTRACT The study was a cross-sectional descriptive design which investigated factors associated with adherence to MDR-TB medication at Mukono health center IV in Mukono district, Uganda. The estimation of sample size was done using Slovan’s formula, 100 participants were selected of which 67% were females and 33% males. Data was analyzed using Microsoft excel and presented using tables, charts and graphs. The study found that of the 67% females, 60% had knowledge on adherence to MDR-TB while of the 33% males, 45% had knowledge on MDRTB. Family support was an important social factor that contributed to MDR-TB medication adherence since 54% had treatments observed by a family member. Distance from health facility affected adherence of 25% of the respondents and 30% of the respondents who did not receive enough patient-health provider time affected 25% of the respondents when they experienced medication side effects. The study concluded that majority of respondents had knowledge on adherence to MDR-TB treatment, family support was an important social factor associated with adherence and distance from the hospital and contact time between patient and health practitioner were vital health facility related factors associated with adherence. The study also recommended that citizens should be educated on MDR-TB during initiation of treatment in order to improve patient support hence improving adherence, follow up of patients who live far from the health facility, appropriately counselling for patients and further research should be conducted on social factors affecting adherence considering it plays a very vital role in the treatment process

Subscribe to access this work and thousands more
Save
Need help with your academic research project/paper, technical or creative writing? Hire our expert researchers and writers. Click Here to Submit a Writing Request
Overall Rating

0

5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
APA

Frontiers, E. & DAVID, K (2022). Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv. Afribary. Retrieved from https://afribary.com/works/factors-associated-with-adherence-to-mdr-tb-medication-in-mukono-district-a-case-study-of-mukono-hc-iv

MLA 8th

Frontiers, Edu, and KALULE DAVID "Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv" Afribary. Afribary, 05 Aug. 2022, https://afribary.com/works/factors-associated-with-adherence-to-mdr-tb-medication-in-mukono-district-a-case-study-of-mukono-hc-iv. Accessed 12 Aug. 2022.

MLA7

Frontiers, Edu, and KALULE DAVID . "Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv". Afribary, Afribary, 05 Aug. 2022. Web. 12 Aug. 2022. < https://afribary.com/works/factors-associated-with-adherence-to-mdr-tb-medication-in-mukono-district-a-case-study-of-mukono-hc-iv >.

Chicago

Frontiers, Edu and DAVID, KALULE . "Factors Associated with Adherence to Mdr-Tb Medication in Mukono District A Case Study of Mukono Hc Iv" Afribary (2022). Accessed August 12, 2022. https://afribary.com/works/factors-associated-with-adherence-to-mdr-tb-medication-in-mukono-district-a-case-study-of-mukono-hc-iv